Evidence map›Paper›PMID 36704840›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2023

Regulation of Photosensitivity by the Hippo Pathway in Lupus Skin.

Grace A Hile, Patrick Coit, Bin Xu, Amanda M Victory, Mehrnaz Gharaee-Kermani, Shannon N Estadt, Mitra P Maz, Jacob W S Martens, Rachael Wasikowski, Craig Dobry and 7 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The Role of Vitamin D in Autoimmune Diseases.International journal of molecular sciences · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Research progress on Hippo signaling pathway effector molecules in rheumatic immune system diseases.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2024
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Grace A HileDepartment of Dermatology, University of Michigan, Ann Arbor.
Patrick CoitDivision of Rheumatology and Graduate Program in Immunology, University of Michigan, Ann Arbor, and Departments of Pediatrics, Medicine, and Immunology, and Lupus Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania.
Bin XuDivision of Rheumatology, University of Michigan, Ann Arbor.
Amanda M VictoryDivision of Rheumatology, University of Michigan, Ann Arbor.
Mehrnaz Gharaee-KermaniDivision of Rheumatology, Department of Internal Medicine and Department of Dermatology, University of Michigan, Ann Arbor.
Shannon N EstadtGraduate Program in Immunology, University of Michigan, Ann Arbor.
Mitra P MazGraduate Program in Immunology, University of Michigan, Ann Arbor.ORCID 0000-0002-2359-0862
Jacob W S MartensGraduate Program in Immunology, University of Michigan, Ann Arbor.
Rachael WasikowskiDepartment of Dermatology and Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor.
Craig DobryDepartment of Dermatology, University of Michigan, Ann Arbor.
Lam C TsoiDepartment of Dermatology, Department of Computational Medicine & Bioinformatics, and Department of Biostatistics, University of Michigan, Ann Arbor.
Ramiro Iglesias-BartolomeLaboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Celine C BerthierDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor.
Allison C BilliDepartment of Dermatology, University of Michigan, Ann Arbor.
Johann E GudjonssonDepartment of Dermatology, University of Michigan, Ann Arbor.
Amr H SawalhaDepartments of Pediatrics, Medicine, and Immunology, and Lupus Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0002-3884-962X
J Michelle KahlenbergDivision of Rheumatology, Department of Internal Medicine and Department of Dermatology, University of Michigan, Ann Arbor.ORCID 0000-0002-4006-8945
University of Michigan · USUniversity of Pittsburgh · USNational Cancer Institute · US

Funding

MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
Signaling pathways regulating stem cell fate decisionsZIABC011763 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI IGLESIAS-BARTOLOME, RAMIRO · 2017 to 2025
$7.5M
University of Michigan Skin Biology and Diseases Resource-based CenterP30AR075043 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Johann Eli Gudjonsson · 2019 to 2026
$6.6M
TRAINING PROGRAM IN CELL AND MOLECULAR DERMATOLOGYT32AR007197 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JAMES TILFORD ELDER, Sunny Y Wong · 1986 to 2026
$4.2M
Role of the sex biased transcription factor VGLL3 in promoting autoimmune responses in SLER01AI130025 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Johann Eli Gudjonsson · 2017 to 2026
$3.9M
Characterization of Interferon Kappa as a Novel Target in Cutaneous LupusR01AR071384 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joanne Michelle Kahlenberg · 2017 to 2026
$3.6M
Hippo signaling as a critical regulator of lupus keratinocyte dysfunctionR01AR081640 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joanne Michelle Kahlenberg · 2022 to 2026
$2.4M
Linking Disease Mechanisms and Outcomes in Rheumatic DiseasesK24AR076975 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joanne Michelle Kahlenberg · 2020 to 2026
$910k
Mechanisms of sex discrepancy in autoimmune disease: Regulation of the female-biased VGLL3 immune pathwayK08AR078251 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BILLI, ALLISON CHELSA · 2021 to 2025
$865k
Role of the Psoriasis Associated IL23R Risk Variants on Th17 Biology and FunctionK08AR060802 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GUDJONSSON, JOHANN ELI · 2011 to 2015
$636k
Understanding Transcriptional Connections between Cutaneous and Systemic LupusR03AR066337 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAHLENBERG, JOANNE MICHELLE · 2014 to 2016
$233k
NIAID NIH HHS R01 AI130025NIAID NIH HHS T32 AI007413NIAMS NIH HHS F31 AR077988NIAMS NIH HHS K08 AR060802NIAMS NIH HHS K08 AR078251NIAMS NIH HHS K24 AR076975NIAMS NIH HHS K24-AR076975NIAMS NIH HHS P30 AR075043NIAMS NIH HHS R01-AR060802NIAMS NIH HHS R01 AR071384NIAMS NIH HHS R01 AR081640NIAMS NIH HHS R03 AR066337NIAMS NIH HHS R03-AR066337NIAMS NIH HHS T32 AR007197NIAMS NIH HHS T32-AR007197NIGMS NIH HHS T32 GM007863
6 · The paper itself

Abstract

objectivePhotosensitivity is one of the most common manifestations of systemic lupus erythematosus (SLE), yet its pathogenesis is not well understood. The normal-appearing epidermis of patients with SLE exhibits increased ultraviolet B (UVB)-driven cell death that persists in cell culture. Here, we investigated the role of epigenetic modification and Hippo signaling in enhanced UVB-induced apoptosis seen in SLE keratinocytes.

methodsWe analyzed DNA methylation in cultured keratinocytes from SLE patients compared to keratinocytes from healthy controls (n = 6/group). Protein expression was validated in cultured keratinocytes using immunoblotting and immunofluorescence. An immortalized keratinocyte line overexpressing WWC1 was generated via lentiviral vector. WWC1-driven changes were inhibited using a large tumor suppressor kinase 1/2 (LATS1/2) inhibitor (TRULI) and small interfering RNA (siRNA). The interaction between the Yes-associated protein (YAP) and the transcriptional enhancer associate domain (TEAD) was inhibited by overexpression of an N/TERT cell line expressing a tetracycline-inducible green fluorescent protein-tagged protein that inhibits YAP-TEAD binding (TEADi). Apoptosis was assessed using cleaved caspase 3/7 and TUNEL staining.

resultsHippo signaling was the top differentially methylated pathway in SLE versus control keratinocytes. SLE keratinocytes (n = 6) showed significant hypomethylation (Δβ = -0.153) and thus overexpression of the Hippo regulator WWC1 (P = 0.002). WWC1 overexpression increased LATS1/2 kinase activation, leading to YAP cytoplasmic retention and altered proapoptotic transcription in SLE keratinocytes. Accordingly, UVB-mediated apoptosis in keratinocytes could be enhanced by WWC1 overexpression or YAP-TEAD inhibition, mimicking SLE keratinocytes. Importantly, inhibition of LATS1/2 with either the chemical inhibitor TRULI or siRNA effectively eliminated enhanced UVB-apoptosis in SLE keratinocytes.

conclusionOur work unravels a novel driver of photosensitivity in SLE: overactive Hippo signaling in SLE keratinocytes restricts YAP transcriptional activity, leading to shifts that promote UVB apoptosis.

Indexed as

Hippo Signaling PathwayLupus Erythematosus, SystemicHumansIntracellular Signaling Peptides and ProteinsKeratinocytesProtein Serine-Threonine KinasesRNA, Small InterferingIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesRNA, Small InterferingWWC1 protein, human

Identifiers

PMID36704840
PMCPMC10313771
OpenAlexW4318203668

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.